Aldeyra Therapeutics, Inc. (ALDX) vs Rein Therapeutics Inc. (RNTX)

Aldeyra Therapeutics, Inc. and Rein Therapeutics Inc. are both Biotechnology companies. Aldeyra Therapeutics, Inc. and Rein Therapeutics Inc. are of similar size ($73.8M and $73.6M). Across the 8 metrics below, Aldeyra Therapeutics, Inc. leads on 6 and Rein Therapeutics Inc. on 2.

Valuation

Metric ALDX RNTX Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.93 4.93 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (32.23%) (229.33%) (28.84%)
Free cash flow yield (30.20%) (37.22%) (23.03%)

Profitability

Metric ALDX RNTX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (49.48%) (753.55%) (57.72%)
Return on assets (34.80%) (80.62%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALDX RNTX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 40.43% 44.16% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALDX RNTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.91 4.27 4.73
Net debt to EBITDA 1.52 0.15 0.96

Dividend

Metric ALDX RNTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ALDX RNTX Biotechnology median
Market cap 73.60m 73.80m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack